{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:13:49Z","timestamp":1787688829944,"version":"build-2784847793"},"reference-count":65,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2016.01889","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T08:51:28Z","timestamp":1479977488000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells"],"prefix":"10.3389","volume":"7","author":[{"given":"Bonto","family":"Faburay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen A.","family":"Richt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1086\/345671","article-title":"Epidemic Rift Valley fever in Saudi Arabia: a clinical study of severe illness in humans.","volume":"36","author":"Al-Hazmi","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4269\/ajtmh.2010.09-0293","article-title":"Risk factors for severe Rift Valley fever infection in Kenya, 2007.","volume":"83","author":"Anyangu","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3201\/eid1912.121527","article-title":"Epidemiologic investigations into outbreaks of Rift Valley fever in humans, South Africa 2008-2011.","volume":"19","author":"Archer","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0924-8579(02)00295-9","article-title":"Rift valley fever: an uninvited zoonosis in the Arabian Peninsula.","volume":"21","author":"Balkhy","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0006-291X(02)02013-2","article-title":"Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo.","volume":"296","author":"Bertrand","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.virol.2008.05.033","article-title":"RNA polymerase I-mediated expression of viral RNA for the rescue of infectious virulent and avirulent Rift Valley fever viruses.","volume":"378","author":"Billecocq","year":"2008","journal-title":"Virology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.","volume":"78","author":"Billecocq","year":"2004","journal-title":"J. Virol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1128\/jvi.02501-07","article-title":"Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals.","volume":"82","author":"Bird","year":"2008","journal-title":"J. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"12901","DOI":"10.1128\/jvi.06046-11","article-title":"Rift valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.","volume":"85","author":"Bird","year":"2011","journal-title":"J. Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1060028014561227","article-title":"Potential and emerging treatment options for Ebola virus disease.","volume":"49","author":"Bishop","year":"2015","journal-title":"Ann. Pharmacother."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs.","volume":"75","author":"Bouloy","year":"2001","journal-title":"J. Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s13149-015-0417-y","article-title":"[Severe hemorrhagic form of Rift Valley fever in mauritania].","volume":"108","author":"Boushab","year":"2015","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"B13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1535-6108(02)00122-8","article-title":"Stable suppression of tumorigenicity by virus-mediated RNA interference.","volume":"2","author":"Brummelkamp","year":"2002","journal-title":"Cancer Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development.","volume":"66","author":"Caplen","year":"1985","journal-title":"J. Gen. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/path.1700340418","article-title":"Enzootic hepatitis or Rift Valley fever. An undescribed virus disease of sheep, cattle and man from East Africa.","volume":"34","author":"Daubney","year":"1931","journal-title":"J. Pathol. Bacteriol."},{"issue":"e1001997","key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001997","article-title":"Experimental treatment of Ebola Virus disease with TKM-130803: a single-arm phase 2 clinical trial.","volume":"13","author":"Dunning","year":"2016","journal-title":"PLoS Med."},{"key":"B17","author":"ECDC","year":"2014","journal-title":"European Center for Disease Prevention and Control. Outbreak of Ebola Virus Disease in West Africa."},{"key":"B18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"issue":"28132","key":"B19","article-title":"The case for a \u2018one health\u2019 approach to combating vector-borne diseases.","volume":"5","author":"Faburay","year":"2015","journal-title":"Infect. Ecol. Epidemiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1089\/vbz.2014.1650","article-title":"A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.","volume":"14","author":"Faburay","year":"2014","journal-title":"Vector Borne Zoonotic Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/vbz.2012.1285","article-title":"Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep.","volume":"13","author":"Faburay","year":"2013","journal-title":"Vector Borne Zoonotic Dis."},{"issue":"27719","key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/srep27719","article-title":"A recombinant Rift Valley fever virus glycoprotein subunit vaccine confers full protection against Rift Valley fever challenge in sheep.","volume":"6","author":"Faburay","year":"2016","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.2174\/156652405774962263","article-title":"Rift Valley fever virus.","volume":"5","author":"Flick","year":"2005","journal-title":"Curr. Mol. Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/s0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.virol.2006.09.035","article-title":"The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection.","volume":"359","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virol.2006.08.002","article-title":"Synthesis, proteolytic processing and complex formation of N-terminally nested precursor proteins of the Rift Valley fever virus glycoproteins.","volume":"357","author":"Gerrard","year":"2007","journal-title":"Virology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nature00873","article-title":"Short interfering RNA confers intracellular antiviral immunity in human cells.","volume":"418","author":"Gitlin","year":"2002","journal-title":"Nature"},{"key":"B28","article-title":"FDA OKs siRNA Ebola Drug.","author":"Grens","year":"2014","journal-title":"TheScientist"},{"key":"B29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/3-540-27262-3_7","article-title":"RNA interference: its use as antiviral therapy.","volume":"173","author":"Haasnoot","year":"2006","journal-title":"Handb. Exp. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/BF02256311","article-title":"Inhibition of virus replication by RNA interference.","volume":"10","author":"Haasnoot","year":"2003","journal-title":"J. Biomed. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1128\/jvi.02148-08","article-title":"NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.","volume":"83","author":"Habjan","year":"2009","journal-title":"J. Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1093\/infdis\/jiq012","article-title":"Emerging influenza antiviral resistance threats.","volume":"203","author":"Hayden","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"915","key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(12)70305-5","article-title":"Infectious disease surveillance update: Rift Valley fever in Mauritania.","volume":"12","author":"Heald","year":"2012","journal-title":"Lancet Infect. Dis."},{"issue":"169","key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2014.00169","article-title":"Recent outbreaks of Rift Valley fever in East Africa and the middle East.","volume":"2","author":"Himeidan","year":"2014","journal-title":"Front. Public Health"},{"key":"B35","doi-asserted-by":"publisher","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug.","volume":"11(Suppl. 4)","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"B36","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.antiviral.2012.06.001","article-title":"Molecular biology and genetic diversity of Rift Valley fever virus.","volume":"95","author":"Ikegami","year":"2012","journal-title":"Antiviral Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"7262","DOI":"10.1128\/jvi.00135-15","article-title":"Rift Valley fever virus MP-12 vaccine is fully attenuated by a combination of partial attenuations in the S, M, and L segments.","volume":"89","author":"Ikegami","year":"2015","journal-title":"J. Virol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/v3050493","article-title":"The pathogenesis of Rift Valley fever.","volume":"3","author":"Ikegami","year":"2011","journal-title":"Viruses"},{"key":"B39","doi-asserted-by":"publisher","first-page":"E75","DOI":"10.1111\/j.1749-6632.2009.05054.x","article-title":"Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR.","volume":"1171(Suppl. 1)","author":"Ikegami","year":"2009a","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"e1000287","key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000287","article-title":"Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and Inhibits eIF2\u03b1 phosphorylation.","volume":"5","author":"Ikegami","year":"2009b","journal-title":"PLoS Pathog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2933","DOI":"10.1128\/JVI.80.6.2933-2940.2006","article-title":"Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.","volume":"80","author":"Ikegami","year":"2006","journal-title":"J. Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0923-2516(89)80096-2","article-title":"Analytical study of a Rift Valley fever epidemic.","volume":"140","author":"Jouan","year":"1989","journal-title":"Res. Virol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"8267","DOI":"10.1128\/jvi.00766-15","article-title":"Robust protection against highly virulent foot-and-mouth disease virus in swine by combination treatment with recombinant adenoviruses expressing porcine alpha and gamma interferons and multiple small interfering RNAs.","volume":"89","author":"Kim","year":"2015","journal-title":"J. Virol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1126\/science.348.6242.1406","article-title":"Surviving Ebola survival.","volume":"348","author":"Kupferschmidt","year":"2015","journal-title":"Science"},{"issue":"e0003548","key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003548","article-title":"Factors associated with severe human Rift Valley fever in Sangailu, Garissa County, Kenya.","volume":"9","author":"LaBeaud","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/s0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"issue":"e13","key":"B47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells.","volume":"4","author":"Le May","year":"2008","journal-title":"PLoS Pathog."},{"key":"B48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4161\/hv.6.7.11761","article-title":"Rift Valley fever virus: an unrecognized emerging threat?","volume":"6","author":"Mandell","year":"2010","journal-title":"Hum. Vaccin."},{"key":"B49","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nm1486","article-title":"In vivo imaging of siRNA delivery and silencing in tumors.","volume":"13","author":"Medarova","year":"2007","journal-title":"Nat. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3201\/eid0812.020194","article-title":"Isolation and genetic characterization of Rift Valley fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia.","volume":"8","author":"Miller","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"28024","key":"B51","doi-asserted-by":"publisher","DOI":"10.3402\/iee.v5.28024","article-title":"A systematic review of Rift Valley fever epidemiology 1931-2014.","volume":"5","author":"Nanyingi","year":"2015","journal-title":"Infect. Ecol. Epidemiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.2010.09-0288","article-title":"An investigation of a major outbreak of Rift Valley fever in Kenya: 2006-2007.","volume":"83","author":"Nguku","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1099\/0022-1317-69-4-817","article-title":"Characterization of attenuated strains of Rift Valley fever virus.","volume":"69(Pt 4)","author":"Rossi","year":"1988","journal-title":"J. Gen. Virol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1099\/0022-1317-78-11-2853","article-title":"Variability of the NS(S) protein among Rift Valley fever virus isolates.","volume":"78(Pt 11)","author":"Sall","year":"1997","journal-title":"J. Gen. Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine.","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"B56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4269\/ajtmh.2010.09-0319","article-title":"Rift Valley fever virus epidemic in Kenya, 2006\/2007: the entomologic investigations.","volume":"83","author":"Sang","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B57","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.antiviral.2014.01.016","article-title":"Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment.","volume":"104","author":"Scharton","year":"2014","journal-title":"Antiviral Res."},{"key":"B58","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1084\/jem.59.3.305","article-title":"RIFT VALLEY FEVER IN MAN : REPORT OF A FATAL LABORATORY INFECTION COMPLICATED BY THROMBOPHLEBITIS.","volume":"59","author":"Schwentker","year":"1934","journal-title":"J. Exp. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3851\/imp2073","article-title":"Pathogenic effects of Rift Valley fever virus NSs gene are alleviated in cultured cells by expressed antiviral short hairpin RNAs.","volume":"17","author":"Scott","year":"2012","journal-title":"Antivir. Ther."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.3201\/eid0812.020195","article-title":"Genetic analysis of viruses associated with emergence of Rift Valley fever in Saudi Arabia and Yemen, 2000-01.","volume":"8","author":"Shoemaker","year":"2002","journal-title":"Emerg. Infect. Dis."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","article-title":"Ribavirin\u2013current status of a broad spectrum antiviral agent.","volume":"2","author":"Snell","year":"2001","journal-title":"Expert Opin. Pharmacother."},{"key":"B62","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3201\/eid2002.131000","article-title":"Rift Valley fever outbreak, southern Mauritania, 2012.","volume":"20","author":"Sow","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature14442","article-title":"Lipid nanoparticle siRNA treatment of Ebola-virus-Makona-infected nonhuman primates.","volume":"521","author":"Thi","year":"2015","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"13335","DOI":"10.1128\/JVI.01238-07","article-title":"NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis.","volume":"81","author":"Won","year":"2007","journal-title":"J. Virol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm1076","article-title":"RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.","volume":"10","author":"Xia","year":"2004","journal-title":"Nat. Med."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2016.01889\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T08:51:28Z","timestamp":1479977488000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2016.01889\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":65,"URL":"https:\/\/doi.org\/10.3389\/fmicb.2016.01889","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]}}}